Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-30

FDA Approved: VEVYE — Original Application (Harrow Eye, LLC)

View source ↗

Summary

FDA approved VEVYE, a cyclosporine ophthalmic solution, from Harrow Eye, LLC, through its original NDA. It is indicated for the treatment of dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VEVYE (CYCLOSPORINE OPHTHALMIC SOLUTION)

Snippet

ORIG AP for VEVYE (CYCLOSPORINE OPHTHALMIC SOLUTION)